Clinical and Developmental Immunology (Jan 2007)

Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy

  • Levent Sutcigil,
  • Cagatay Oktenli,
  • Ugur Musabak,
  • Ali Bozkurt,
  • Adnan Cansever,
  • Ozcan Uzun,
  • S. Yavuz Sanisoglu,
  • Zeki Yesilova,
  • Nahit Ozmenler,
  • Aytekin Ozsahin,
  • Ali Sengul

DOI
https://doi.org/10.1155/2007/76396
Journal volume & issue
Vol. 2007

Abstract

Read online

The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.